RCUS
Arcus Biosciences Inc
26.40$
-1.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -484.6% | – | – | – | – | – | – | – | |
| – | +200.0% | +0.0% | -33.3% | +0.0% | +50.0% | +0.0% | -33.3% | +0.0% | +50.0% | -33.3% | +50.0% | – | |
| – | +0.0% | +11.1% | +0.0% | -5.0% | -10.5% | -5.9% | -6.3% | -6.7% | +7.1% | +26.7% | -21.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -122.8% | – | – | – | -242.9% | – | – | – | |
| – | -40.0% | -33.3% | -100.0% | – | +0.0% | +0.0% | -100.0% | – | – | -100.0% | – | – | |
| – | +154.5% | -703.6% | – | -146.0% | – | -37.3% | +328.1% | -42.3% | -330.4% | – | -54.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | -50.0% | +7,533.3% | -99.1% | +2,300.0% | -104.2% | – | -63.4% | -84.6% | +3,475.0% | -99.0% | +433.3% | – | |
| – | – | – | -150.0% | – | -213.3% | – | +33.3% | -117.9% | – | – | – | – | |
| – | – | – | – | – | -504.0% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.